United States · FDA National Drug Code directory
TEMOZOLOMIDE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 16571-816_b75f958e-33bc-434d-a4ae-e5fa9d6f4ab5
- Product NDC
- 16571-816
- Form
- CAPSULE
- Composition / generic term
- temozolomide
- Labeler
- Rising Pharma Holdings, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20221004
- Source listing expiry
- 20261231
Source-listed ingredients
- TEMOZOLOMIDE — 5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 20 CAPSULE in 1 BOTTLE (16571-816-02) · 16571-816-02
- 14 CAPSULE in 1 BOTTLE (16571-816-41) · 16571-816-41
- 5 CAPSULE in 1 BOTTLE (16571-816-51) · 16571-816-51
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →